Results 231 to 240 of about 11,670 (284)

Successful Treatment of Paediatric Necrobiosis Lipoidica With Baricitinib

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Necrobiosis lipoidica (NL) is a rare, chronic granulomatous condition that typically presents as sharply demarcated plaques with telangiectasia and atrophic centres. Paediatric cases are uncommon, and treatment options often fail to address refractory cases.
P. Simões Farinha, M. J. Paiva‐Lopes
wiley   +1 more source

Dupilumab Treatment in Pemphigus: A Report of Three Cases and Literature Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Pemphigus vulgaris (PV) and foliaceus (PF) are rare autoimmune blistering diseases traditionally treated with systemic corticosteroids, immunosuppressants, intravenous immunoglobulins, and rituximab. Nonetheless, a subset of patients remains refractory or has contraindications to these conventional therapies.
José Javier Mateos Rico   +5 more
wiley   +1 more source

Is There Benefit in Treating Traction Alopecia With Minoxidil? A Systematic Review

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Traction alopecia (TA) is common condition. Although no treatment guidelines exist, minoxidil can be adjunctively added to behavioural modification strategies. Objectives This systematic review aimed to evaluate the impact of adjunctive minoxidil on the severity of TA.
Husna Moola   +3 more
wiley   +1 more source

Scalp haircuts, keloids and blood-borne virus transmission risk in South Africa-The SHAKA study. [PDF]

open access: yesPLoS One
Khumalo N   +10 more
europepmc   +1 more source

Patient Characteristics, Disease Profile and Treatment Patterns in Mild and Moderate Psoriasis Patients: Results From Real‐World Clinical Practices in Five European Countries (PROSPECT Study)

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Categorisation of psoriasis (PsO) disease severity in patients varies, although body surface area (BSA) affected is commonly used (< 3% ‘mild’, 3%–10% ‘moderate’ and > 10% ‘severe’). While moderate‐severe PsO has been well‐studied, more limited information regarding mild‐to‐moderate PsO is available.
Emily Goddard   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy